Propafenone clinical trials
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses Propafenone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 27 Nov 1989 · RYTHMOL · NDA 019151 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 6
Charles University, Czech Republic (1) · TSH Biopharm Corporation Limited (1) · Pharmtechnology LLC (1) · GlaxoSmithKline (1) · Samsung Medical Center (1) · University of Pennsylvania (1) · Uppsala University Hospital (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
Often tested with
Tested in the same studies.
Amiodarone (3) · Sotalol (3) · Dronedarone (2) · Flecainide (2) · Dofetilide (1) · Disopyramide (1)
Studies
Open first, then newest update. How each study uses Propafenone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Beta-blocker vs. Ic Antiarrhythmic Drug for PVCWithdrawnNot applicableYong Seog OhNCT03561935Written as Propafenone
- Propafenone Versus Amiodarone in Septic ShockCompletedPhase 4Charles University, Czech RepublicNCT03029169Written as Propafenone i.v.
- Propafenone in the Treatment of Atrial FibrillationCompletedNot applicableTSH Biopharm Corporation LimitedNCT03674658Written as Propafenone
- Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting ConditionsCompletedPhase 1Pharmtechnology LLCNCT03915340Written as Propafenone
- Bioequivalence of RYTHMOL SR® Manufactured at Two Different SitesCompletedPhase 1GlaxoSmithKlineNCT01956487Written as Propafenone
- Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)Status unknownNot applicableUppsala University HospitalNCT02294955Written as Propafenone
- Antiarrhythmic Drugs Assessment in Preventing Atrial FibrillationStatus unknownPhase 4Xinhua Hospital, Shanghai Jiao Tong University School of MedicineNCT02145546Written as Propafenone
- Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationCompletedNot applicableSamsung Medical CenterNCT01991119Written as Propafenone
- A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation AblationCompletedNot applicableUniversity of PennsylvaniaNCT00408200Written as propafenone; flecainide; sotalol; dofetilide
As the comparator · 6 — what is tested is compared with Propafenone
- Dronedarone Rhythm Intervention for Early Atrial FibrillationNot yet recruitingPhase 4Inha University HospitalNCT07270848Written as propafenone
- Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.RecruitingPhase 4Centre of Postgraduate Medical EducationNCT05720572Written as Propafenone
- Efficacy and Safety of Sotalol in Children With ArrhythmiaStatus unknownPhase 4Shengjing HospitalNCT03895411Written as Propafenone
- Comparison of Brain Perfusion in Rhythm Control and Rate Control of Persistent Atrial FibrillationStatus unknownNot applicableYonsei UniversityNCT02633774Written as Propafenone
- Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial FibrillationCompletedNot applicableValduce HospitalNCT00933634Written as propafenone
- High Intensity Focused Ultrasound (HIFU) Ablation System StudySuspendedPhase 3ProRhythm, Inc.NCT00392106Written as propafenone
Codes
What other systems call Propafenone · ClinicalTrials.gg INT008108
- MeSH (NLM) D011405PropafenoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 68IQX3T69UPROPAFENONEConfirmed FDA, NLM, Wikidata
- RxNorm 8754Confirmed FDA, Wikidata
- Wikidata Q662511(RS)-propafenoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61909PropafenoneOne source FDA
- DrugBank DB01182One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D011405 | Propafenone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 68IQX3T69U | PROPAFENONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 8754 | — | Confirmed FDA, Wikidata |
| Wikidata | Q662511 | (RS)-propafenone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61909 | Propafenone | One source FDA |
| DrugBank | DB01182 | — | One source Wikidata |
Also registered as propafenone hydrochloride (UNII 33XCH0HOCD · RxNorm 203135).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.